---
figid: PMC8732282__41388_2021_2077_Fig8_HTML
figtitle: Proposed model depicting the therapeutic mechanism of GRB7-PLK1 axis inhibition
  to overcome MEKi resistance in KRAS mutant colon cancer cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8732282
filename: 41388_2021_2077_Fig8_HTML.jpg
figlink: /pmc/articles/PMC8732282/figure/Fig8/
number: F8
caption: A In KRAS mutant CRC cells, GRB7 confers MEKi resistance through mediating
  the RTK pathway. B Combination AZD6244 and GRB7-PLK1 axis inhibition significantly
  suppresses the proliferation and induces apoptosis through attenuating RTK signaling.
papertitle: Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver
  for MEK inhibitor resistance in KRAS mutant colon cancer.
reftext: Chune Yu, et al. Oncogene. 2022;41(2):191-203.
year: '2022'
doi: 10.1038/s41388-021-02077-w
journal_title: Oncogene
journal_nlm_ta: Oncogene
publisher_name: Nature Publishing Group UK
keywords: Cancer therapeutic resistance | Targeted therapies | Colorectal cancer
automl_pathway: 0.9015718
figid_alias: PMC8732282__F8
figtype: Figure
redirect_from: /figures/PMC8732282__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8732282__41388_2021_2077_Fig8_HTML.html
  '@type': Dataset
  description: A In KRAS mutant CRC cells, GRB7 confers MEKi resistance through mediating
    the RTK pathway. B Combination AZD6244 and GRB7-PLK1 axis inhibition significantly
    suppresses the proliferation and induces apoptosis through attenuating RTK signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - E(spl)malpha-BFM
  - Akt
  - polo
  - Fak
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - GRB7
  - PLK1
  - STAT3
  - PTK2
---
